Skip to Content

653 (Glyburide and Metformin Hydrochloride 1.25 mg / 250 mg)

Pill with imprint 653 is White, Capsule-shape and has been identified as Glyburide and Metformin Hydrochloride 1.25 mg / 250 mg. It is supplied by Cadila Healthcare Limited.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 1.25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 653

Glyburide and metformin hydrochloride 1.25 mg / 250 mg 653

Glyburide and Metformin Hydrochloride

Imprint
653
Strength
1.25 mg / 250 mg
Color
White
Size
13.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cadila Healthcare Limited
National Drug Code (NDC)
65841-0824
Inactive Ingredients
calcium carbonate, microcrystalline cellulose, croscarmellose sodium, hypromellose 2910 (6 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 6000, povidone k29/32, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "653"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.